Estimating the financial cost of chronic kidney disease to the NHS in England. - Wikidata - wikimedia - TriplyDB

Estimating the financial cost of chronic kidney disease to the NHS in England.

Estimating the financial cost of chronic kidney disease to the NHS in England.

http://www.wikidata.org/entity/Q36358702

about

Chronic kidney disease: identification and management in primary care The need for improved identification and accurate classification of stages 3-5 Chronic Kidney Disease in primary care: retrospective cohort study Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Home hemodialysis: a comprehensive review of patient-centered and economic considerations Variation in centre-specific survival in patients starting renal replacement therapy in England is explained by enhanced comorbidity information from hospitalization data.Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial.A review of the use of health examination data from the Health Survey for England in government policy development and implementation.Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trust DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease Inpatient coronary angiography and revascularisation following non-ST-elevation acute coronary syndrome in patients with renal impairment: a cohort study using the Myocardial Ischaemia National Audit Project.Psychosocial Interventions for Depressive and Anxiety Symptoms in Individuals with Chronic Kidney Disease: Systematic Review and Meta-Analysis.Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases Peritoneal dialysis and in-centre haemodialysis: a cost-utility analysis from a UK payer perspective.Change in prevalence of chronic kidney disease in England over time: comparison of nationally representative cross-sectional surveys from 2003 to 2010.The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study A prospective clinical trial of specialist renal nursing in the primary care setting to prevent progression of chronic kidney: a quality improvement report.Addressing health disparities in chronic kidney disease.Active vitamin D treatment for reduction of residual proteinuria: a systematic review.A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan.Timeliness in chronic kidney disease and albuminuria identification: a retrospective cohort study Is routine hospital episode data sufficient for identifying individuals with chronic kidney disease? A comparison study with laboratory data.Acute Care QUAliTy in chronic Kidney disease (ACQUATIK): a prospective cohort study exploring outcomes of patients with chronic kidney disease.Statins and Cardiovascular Primary Prevention in CKD: A Meta-Analysis.What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?Development of a Model of Chronic Kidney Disease in the C57BL/6 Mouse with Properties of Progressive Human CKD.Are pre-existing markers of chronic kidney disease associated with short-term mortality following acute community-acquired pneumonia and sepsis? A cohort study among older people with diabetes using electronic health records PAlliative Care in chronic Kidney diSease: the PACKS study--quality of life, decision making, costs and impact on carers in people managed without dialysis.The cost of dialysis in low and middle-income countries: a systematic review An external validation of models to predict the onset of chronic kidney disease using population-based electronic health records from Salford, UK.Budget impact of secondary hyperparathyroidism treatment in chronic kidney disease in an Ecuadorian social security hospital.Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England.Cost Effectiveness of Sucroferric Oxyhydroxide Compared with Sevelamer Carbonate in the Treatment of Hyperphosphataemia in Patients Receiving Dialysis, from the Perspective of the National Health Service in Scotland.A two-stage approach to the joint analysis of longitudinal and survival data utilising the Coxian phase-type distribution.What drives quality improvement in chronic kidney disease (CKD) in primary care: process evaluation of the Quality Improvement in Chronic Kidney Disease (QICKD) trial.Estimation of the prevalence of chronic kidney disease: The results of a model based estimation in Kerman, Iran.Modulation of endogenous antioxidant defense and the progression of kidney disease in multi-heritage groups of patients with type 2 diabetes: PRospective EValuation of Early Nephropathy and its Treatment (PREVENT)Cost-effectiveness analysis of different systolic blood pressure targets for people with a history of stroke or transient ischaemic attack: Economic analysis of the PAST-BP study.Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.

P2860

Q28066936-EABD1460-D3FD-411F-9E0D-EA40B1CFEB8D Q28541795-39ECD4DF-99C3-4D86-8DC0-375A01C13C6A Q30234324-58653366-2F76-4605-BDC3-0471C78CE7F9 Q30399190-7E33DC4C-5DEB-4B34-8CA7-C3299CC0321D Q30486377-B4407A69-1604-4AF3-9AA1-A444056E6788 Q30585060-0E157A4D-F697-4E2B-8CB6-73B908349177 Q30842182-B9C6DBB0-038D-4CED-8047-02C09358748C Q33713158-DF2DDCCA-5915-426F-AED6-DC86200A40A3 Q33740666-D859F329-CCA0-471C-BF42-63366BCFC3AA Q33769037-F51E9CF8-6B99-4613-B1F9-30AE6630F5E6 Q33790497-7586686D-FA5F-4B86-A948-40408F3F9C80 Q33821915-E4BACB98-10FA-47F3-BC8F-2CF166E47DA1 Q33838866-D6221D8A-2FF7-4336-B2E8-3DBC53A83ED3 Q33947650-A17F09E7-17A1-4CD2-804E-8C52D6C7D4D6 Q34264752-CF61A7CB-BA08-4B5D-864D-649218841E4A Q34325736-2F16EA49-9419-4FE3-B994-69DA125E5146 Q34647118-A91CD76F-7461-4AA1-A5D4-97087B5C1344 Q34677102-96BF7FAF-0DAE-4F23-94A2-DFA10223D94F Q34773512-9E2410ED-2223-45FD-A993-A49B11A49CC6 Q34912750-70732353-A782-45AF-A25C-309BE15B479B Q35095348-AF7FB4B0-6B65-4A51-B74B-168A032AA0E3 Q35097364-65B3ED6E-92B1-4E49-99E8-DF850EC45C3D Q35536667-F59B190C-A9FB-4151-99AC-F490853E35DE Q35573137-A5D9733F-F0DB-4ADA-A6F0-CEE6669702FD Q35576102-CA730B8C-E0B7-4DBF-91BA-6791F38299FB Q35583850-4A66D979-A439-4F17-BBF0-F21AC1D260D3 Q35612465-963B1917-1C3A-485D-81CE-F2668D47DAC7 Q35627694-7B678F60-4356-4C79-8227-285F4DDB242C Q35688619-568B3A09-3532-489B-A57F-0C72FF2404A9 Q35840189-3EC2C580-B8B5-413C-A8F7-CF07B6C6DB71 Q36073005-08AEB8C4-79F0-4F3A-AFE2-47EDF79A2847 Q36114718-6180D303-DB0F-4527-94D4-5E4A56F3B594 Q36300946-A6FFBEB4-524A-4B25-955A-76AE5A0EF85A Q36322947-EC4CE7C5-C245-49F1-AD7A-B5C475F1D02C Q36410648-B118A6DC-92C6-4619-8531-6EB904E55678 Q36773285-BEBD2099-0D80-497F-993C-90BF3CC0C5AF Q36983206-9169CA6B-9F83-4477-9A96-C1723202806E Q37151933-0DEBE2B4-4DCF-443B-99F5-6FFB9BE06579 Q37271882-5652D99B-BA27-4387-9362-B0124D8C28B1 Q37356124-F4481D55-FD0C-42A6-A14F-FD5A8B51104A

P2860

Estimating the financial cost of chronic kidney disease to the NHS in England.

http://www.wikidata.org/entity/Q36358702

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Estimating the financial cost of chronic kidney disease to the NHS in England.

@ast

Estimating the financial cost of chronic kidney disease to the NHS in England.

@en

type

label

Estimating the financial cost of chronic kidney disease to the NHS in England.

@ast

Estimating the financial cost of chronic kidney disease to the NHS in England.

@en

prefLabel

Estimating the financial cost of chronic kidney disease to the NHS in England.

@ast

Estimating the financial cost of chronic kidney disease to the NHS in England.

@en

P1433

Q36358702-2ACA2348-9975-4FC4-A986-75C0B019ECA6

P1476

Q36358702-2E2E605E-24AC-4F9B-8673-54BDD29C60A5

P2093

Q36358702-20939453-E71B-4452-8B11-CF11EDF44CFD

Q36358702-43144981-2DAD-4C13-BEF3-53B5D07A33B3

Q36358702-8CE68605-8EB3-4384-918D-14F26FC97B3A

Q36358702-ADDD669B-CE31-4318-B694-6E6BCF5DF4DE

Q36358702-CF569186-3404-413E-B74A-6657CA6CA678

P2860

Q36358702-08826915-55FF-4FD1-B767-6CAC1864CADE

Q36358702-1E4AF013-41A7-4723-9C3D-7D33A451E4FC

Q36358702-20079013-D83E-4570-BB83-1FE034BE54EF

Q36358702-245A495B-4946-4E83-8FF4-EC82C6A668A5

Q36358702-2EF52632-0DD8-4D65-91CC-1124250DED2F

Q36358702-4A6C6198-66F1-4666-8122-42AB8C3A5BF5

Q36358702-5E458C75-9776-40EA-BF77-EF974DD92489

Q36358702-77F35BBD-F390-46FE-AACF-3F6FAC0B8673

Q36358702-79F2B510-4F31-4A4D-9C00-94BCE83FC5FF

Q36358702-810F5E6C-B873-43BA-8916-DC6016DC0EC0

P304

Q36358702-61A54D89-6E96-4680-95BF-90110F20314A

P31

Q36358702-B9E5E6F5-1FEF-4C25-BA8A-67077DD64F2E

P356

Q36358702-311258FA-4718-44AF-8133-4FB065DEA9C3

P407

Q36358702-98F7F3D4-E163-4368-9C09-487BA6F22C99

P478

Q36358702-10671D90-2173-4DB0-949E-19113806E245

P577

Q36358702-A7E5407E-4BC7-436B-A6AC-493D0357823C

P5875

Q36358702-EB78C964-292B-4414-9912-B8CE2C3FD23E

P698

Q36358702-E1BCE5E4-F5AB-4E85-A474-D6A65782E1F4

P932

Q36358702-AA044140-2AA3-4F6B-9778-BC0B5AA7B831

P356

P1433

Nephrology Dialysis Transplantation

P1476

Estimating the financial cost of chronic kidney disease to the NHS in England.

@en

P2093

Benjamin Bray

http://www.w3.org/2001/XMLSchema#string

Beverley Matthews

http://www.w3.org/2001/XMLSchema#string

Donal J O'Donoghue

http://www.w3.org/2001/XMLSchema#string

James Medcalf

http://www.w3.org/2001/XMLSchema#string

Marion Kerr

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data.

Stroke incidence and prevalence in Europe: a review of available data.

Diarrhoea due to Clostridium difficile associated with antibiotic treatment in patients receiving dialysis: the role of cross infection.

Dialysis for end-stage renal disease. Determining a cost-effective approach.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Making change last: applying the NHS institute for innovation and improvement sustainability model to healthcare improvement.

The burden of chronic kidney disease.

Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

P304

iii73-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFS269

http://www.w3.org/2001/XMLSchema#string

P407

P478

27 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229427568

http://www.w3.org/2001/XMLSchema#string

P698

22815543

http://www.w3.org/2001/XMLSchema#string

P932

3484716

http://www.w3.org/2001/XMLSchema#string